Related Experiment Video
Updated: Jul 4, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Post-Capillary Pulmonary Hypertension: Clinical Review
Joshua M Riley1, James J Fradin2, Douglas H Russ1
1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA.
Post-capillary pulmonary hypertension (PH), common in left heart disease, stems from elevated left-sided pressures. Management focuses on treating the underlying heart condition to improve outcomes.
Area of Science:
- Cardiology
- Pulmonology
- Internal Medicine
Background:
- Post-capillary pulmonary hypertension (PH), often linked to left heart disease, is the most prevalent form of PH.
- Causes include heart failure with preserved ejection fraction, valvular heart disease, and atrial fibrillation-related atrial myopathy.
- Elevated left-sided filling pressures lead to pulmonary venous congestion and subsequent PH.
Purpose of the Study:
- To provide a comprehensive review of post-capillary PH.
- To detail its etiologies, pathophysiology, diagnostic criteria, and management strategies.
- To highlight its specific relevance in the context of advanced heart failure.
Main Methods:
- Review of existing literature on post-capillary PH.
- Analysis of hemodynamic definitions and diagnostic tools like echocardiography.
- Synthesis of current management approaches for underlying cardiac conditions.
Main Results:
- Hemodynamic definition: mean pulmonary arterial pressure > 20 mmHg, pulmonary vascular resistance < 3 Wood units, pulmonary capillary wedge pressure > 15 mmHg.
- Chronic congestion can cause pulmonary arterial remodeling, leading to combined pre- and post-capillary PH.
- Management emphasizes treating the primary cardiac issue, including medical therapy, valve interventions, and risk factor control.
Conclusions:
- Effective management of post-capillary PH hinges on addressing the underlying left heart disease.
- Referral to specialized centers improves patient outcomes.
- Further research is needed on targeted therapies for pulmonary arterial hypertension in this context.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

